Company
MaxWell Biosystems
- Biotech
- Founded:
- 2016
- Location:
- Zuerich, Switzerland
Description
MaxWell Biosystems provides high-density microelectrode array (HD-MEA) platforms, combining multiwell and single-well devices with software to record and characterize electrophysiology from neuronal populations to subcellular dynamics for neuroscience research and preclinical drug discovery.
MaxWell Biosystems is located in the Zurich ecosystem.
Related
InSpheroInSphero provides human-tissue 3D in vitro cell-culture models, spheroid and organoid tools, and automation-compatible plates that support…
CovalXCovalX characterizes therapeutic proteins and biologics using mass spectrometry services, including epitope mapping, HDX-MS, XL-MS, LC-MS,…
Dynamic BiosensorsDynamic Biosensors develops switchSENSE® and single-cell Interaction Cytometry (scIC) technologies that characterize molecular interactions…
EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
GratXrayGratXray develops breast cancer imaging technology, including senoa breast CT, combining scientific work with safer, more reliable,…
Numab TherapeuticsNumab Therapeutics engineers multispecific antibodies, combining antibody engineering and Swiss scientific expertise to build a proprietary…
BraineverBrainever develops hEN1 and hOTX2 homeoprotein drug candidates intended to limit neurodegenerative disease progression by preventing…
LUMA VISIONLUMA VISION develops imaging hardware, software and machine-learning systems for interventional cardiac imaging including an…
AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…